Evidence map›Paper›PMID 38809474›Full record

ArticleJournal of autism and developmental disorders2025

Predicting Intervention Use in Youth with Rare Variants in Autism-Associated Genes.

Hannah R Benavidez, Margaret Johansson, Elizabeth Jones, Hannah Rea, Evangeline C Kurtz-Nelson, Conor Miles, Alana Whiting, Curtis Eayrs, Rachel Earl, Raphael A Bernier and 2 more

Abstract read
In one paragraph

Article in Journal of autism and developmental disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hannah R BenavidezDepartment of Psychology, University of Washington, Seattle, WA, USA.
Margaret JohanssonDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Elizabeth JonesDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Hannah ReaDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Evangeline C Kurtz-NelsonDepartment of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.
Conor MilesDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Alana WhitingDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Curtis EayrsDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Rachel EarlDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Raphael A BernierDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA.
Evan E EichlerDepartment of Genome Sciences, University of Washington School of Medicine, Seattle, WA, USA.
Emily NeuhausDepartment of Psychiatry & Behavioral Sciences, University of Washington, Seattle, WA, USA. eneuhaus@uw.edu.ORCID http://orcid.org/0000-0003-1762-0348

Funding

NCCIH Supplement to NCATS/CTSA Program for KL2 Scholars - M. SoddersKL2TR002317 · NCATS · UNIVERSITY OF WASHINGTON · PI Christy Michelle McKinney · 2017 to 2026
$14.5M
Leveraging rare genetic etiologies to advance knowledge and treatment of neurpsychiatric disordersU01MH119705 · NIMH · GEISINGER CLINIC · PI LEDBETTER, DAVID H., MARTIN, CHRISTA LESE · 2019 to 2023
$9.2M
Sporadic Mutations and Autism Spectrum DisordersR01MH101221 · NIMH · UNIVERSITY OF WASHINGTON · PI EICHLER, EVAN · 2013 to 2025
$9.2M
Phenotypic Characterization of Gene Disrupting Mutations in ASDR01MH100047 · NIMH · UNIVERSITY OF WASHINGTON · PI BERNIER, RAPHAEL A · 2014 to 2018
$2.1M
NCATS NIH HHS KL2 TR002317NIMH NIH HHS R01 MH100047NIMH NIH HHS R01MH100047NIMH NIH HHS R01 MH101221NIMH NIH HHS R01MH101221NIMH NIH HHS U01 MH119705NIMH NIH HHS U01MH119705-02S1
6 · The paper itself

Abstract

Specialized multidisciplinary supports are important for long-term outcomes for autistic youth. Although family and child factors predict service utilization in autism, little is known with respect to youth with rare, autism-associated genetic variants, who frequently have increased psychiatric, developmental, and behavioral needs. We investigate the impact of family factors on service utilization to determine whether caregiver (autistic features, education, income) and child (autistic features, sex, age, IQ, co-occurring conditions) factors predicted service type (e.g., speech, occupational, behavioral) and intensity (hours/year) among children with autism-associated variants (N = 125), some of whom also had a confirmed ASD diagnosis. Analyses revealed variability in the types of services used across a range of child demographic, behavioral, and mental health characteristics. Speech therapy was the most received service (87.2%). Importantly, behavior therapy was the least received service and post-hoc analyses revealed that use of this therapy was uniquely predicted by ASD diagnosis. However, once children received a particular service, there was largely comparable intensity of services, independent of caregiver and child factors. Findings suggest that demographic and clinical factors impact families' ability to obtain services, with less impact on the intensity of services received. The low receipt of therapies that specifically address core support needs in autism (i.e., behavior therapy) indicates more research is needed on the availability of these services for youth with autism-associated variants, particularly for those who do not meet criteria for an ASD diagnosis but do demonstrate elevated and impactful child autistic features as compared to the general population.

Indexed as

Autism Spectrum DisorderAutistic DisorderBehavior TherapyAdolescentCaregiversChildChild, PreschoolFemaleHumansMaleSpeech TherapyAutism-associated genesIntensity of servicesService utilization

Identifiers

PMID38809474
PMCPMC11604814

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.